Showing results (231-240 of 387) with videos related to

Sort By:
Pageof 39
Neurocritical Care|May 14, 2010
Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive careChristopher J Taylor, Fergus Robertson, David Brealey, et al.
Trials|June 5, 2014
An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trialRobert M L'E Orme, Gavin D Perkins, Daniel F McAuley, et al.
Intensive Care Medicine Experimental|August 22, 2018
Heart rate elevations during early sepsis predict death in fluid-resuscitated rats with fecal peritonitisAlain Rudiger, Victor Jeger, Mattia Arrigo, et al.
Physiological Reports|March 1, 2018
P2X7 receptor antagonism ameliorates renal dysfunction in a rat model of sepsisNishkantha Arulkumaran, Marije L Sixma, Sean Pollen, et al.
Hypertension (Dallas, Tex. : 1979)|February 26, 2015
Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonistAimee L Brame, Janet J Maguire, Peiran Yang, et al.
Anesthesia and Analgesia|April 2, 2025
Metabolic Flexibility as a Candidate Mechanism for the Development of Postoperative MorbidityPietro Arina, John Whittle, Maciej R Kaczorek, et al.
Shock (Augusta, Ga.)|June 21, 2018
Part III: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Fluid Resuscitation and Antimicrobial Therapy EndpointsJudith Hellman, Soheyl Bahrami, Mihaly Boros, et al.
Frontiers in Physiology|June 7, 2018
Diabetes Worsens Skeletal Muscle Mitochondrial Function, Oxidative Stress, and Apoptosis After Lower-Limb Ischemia-Reperfusion: Implication of the RISK and SAFE Pathways?Julien Pottecher, Chris Adamopoulos, Anne Lejay, et al.
Critical Care Medicine|March 2, 2022
The β 1 -Adrenergic Receptor Contributes to Sepsis-Induced Immunosuppression Through Modulation of Regulatory T-Cell Inhibitory FunctionManon Durand, Eugénie Hagimont, Huguette Louis, et al.
Frontiers in Neuroscience|March 16, 2017
[Pyr1]Apelin-13(1-12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13Peiran Yang, Rhoda E Kuc, Aimée L Brame, et al.
Pageof 39